共 17 条
- [17] Time to clinical recapture after dose escalation of subcutaneous infliximab (CT-P13 SC) following loss of response: A post hoc analysis of the 2-year Phase 3 LIBERTY-CD & LIBERTY-UC trials JOURNAL OF CROHNS & COLITIS, 2025, 19 : I2087 - I2088